[go: up one dir, main page]

WO2007067757A3 - Certains types d'entites chimiques, compositions et methode de modulation de trpv1 - Google Patents

Certains types d'entites chimiques, compositions et methode de modulation de trpv1 Download PDF

Info

Publication number
WO2007067757A3
WO2007067757A3 PCT/US2006/047003 US2006047003W WO2007067757A3 WO 2007067757 A3 WO2007067757 A3 WO 2007067757A3 US 2006047003 W US2006047003 W US 2006047003W WO 2007067757 A3 WO2007067757 A3 WO 2007067757A3
Authority
WO
WIPO (PCT)
Prior art keywords
chemical entities
compositions
methods
certain chemical
trpv1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/047003
Other languages
English (en)
Other versions
WO2007067757A2 (fr
Inventor
Jose S Mendoza
Carl Nicholas Hodge
John K Dickson Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amphora Discovery Corp
Original Assignee
Amphora Discovery Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amphora Discovery Corp filed Critical Amphora Discovery Corp
Publication of WO2007067757A2 publication Critical patent/WO2007067757A2/fr
Publication of WO2007067757A3 publication Critical patent/WO2007067757A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur des entités chimiques choisies parmi des composés de formule (I) et sur des sels acceptables d'un point de vue pharmaceutique ou cosmétique, des solvates, des chélates, des complexes non covalents, des promédicaments et des mélanges de ceux-ci. Les entités chimiques modulent TRPV1 et sont utiles dans le traitement d'au moins une maladie ou trouble modulé par l'activité de TRPV1.
PCT/US2006/047003 2005-12-08 2006-12-05 Certains types d'entites chimiques, compositions et methode de modulation de trpv1 Ceased WO2007067757A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74935105P 2005-12-08 2005-12-08
US60/749,351 2005-12-08

Publications (2)

Publication Number Publication Date
WO2007067757A2 WO2007067757A2 (fr) 2007-06-14
WO2007067757A3 true WO2007067757A3 (fr) 2008-01-31

Family

ID=38123536

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/047003 Ceased WO2007067757A2 (fr) 2005-12-08 2006-12-05 Certains types d'entites chimiques, compositions et methode de modulation de trpv1

Country Status (1)

Country Link
WO (1) WO2007067757A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5643112B2 (ja) 2008-01-28 2014-12-17 アモーレパシフィック コーポレイションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ バニロイド受容体としての新規化合物、その異性体または薬剤学的に許容し得る塩、及びこれを含有する医薬組成物
US8362012B2 (en) 2008-04-18 2013-01-29 Daewoong Pharmaceutical Co., Ltd. Benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
KR101621444B1 (ko) 2008-07-02 2016-05-19 (주)아모레퍼시픽 바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염, 및 이를 포함하는 약학 조성물
KR101293384B1 (ko) 2010-10-13 2013-08-05 주식회사 대웅제약 신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096784A1 (fr) * 2003-04-28 2004-11-11 Astrazeneca Ab Nouveaux amides heterocycliques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096784A1 (fr) * 2003-04-28 2004-11-11 Astrazeneca Ab Nouveaux amides heterocycliques

Also Published As

Publication number Publication date
WO2007067757A2 (fr) 2007-06-14

Similar Documents

Publication Publication Date Title
WO2007067711A3 (fr) Certains types d'entites chimiques, compositions et methode de modulation de trpv1
WO2005005378A3 (fr) Hydrazides d'indolinone utilises en tant qu'inhibiteurs du recepteur c-met
WO2005086661A3 (fr) Composes, compositions pharmaceutiques et procedes d'utilisation dans le traitement de troubles metaboliques
WO2007024717A3 (fr) Agents permettant de prevenir et de traiter des troubles entrainant la modulation des recepteurs ryr
WO2005040116A3 (fr) Derives d'indolinone et utilisations de ceux-ci pour traiter des etats pathologiques tels que le cancer
WO2008062276A3 (fr) Dérivés d'acétylène comme inhibiteurs de la stéaroyl coa désaturase
WO2004080377A3 (fr) Nouveaux composes modulant le canal kcnq et leur utilisation
ATE540024T1 (de) Allosterische modulatoren von metabotropen glutamatrezeptoren
TW200602036A (en) Diphenylazetidone derivates
NO20082145L (no) Prolinamidderivater som natriumkanalmodulatorer
WO2005061452A8 (fr) Derives diphenylazetidinone a activite inhibitrice de l'absorption du cholesterol
CY1112727T1 (el) Παραγωγα κυκλοβουτυλ αμινης βενζοθειαζολης και η χρηση αυτων ως προσδετες των υποδοχεων ισταμινης-3
DE602005017895D1 (de) Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
WO2007062999A3 (fr) Derives de indole-2-yl amide substitues en 1,5
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
ATE472529T1 (de) Prolinamidderivate als natriumkanalmodulatoren
WO2009037542A3 (fr) Composés spirocycliques en tant qu'inhibiteurs de stéaroyle coa désaturase
MY148538A (en) Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
ATE380816T1 (de) Substituierte imidazopyrimidine zur prävention und behandlung von krebs
NO20054787L (no) Indenderivater som farmasotiske midler
WO2007131907A3 (fr) Dérivés de 1h-indol-5-yl-pipérazin-1-yl-méthanone
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
WO2007067757A3 (fr) Certains types d'entites chimiques, compositions et methode de modulation de trpv1
WO2007067756A3 (fr) Certains types d'entites chimiques, compositions et methode de modulation de trpv1

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06845092

Country of ref document: EP

Kind code of ref document: A2